// App-Quantinova.ai

3033 : Immune gene expression, survival outcome and response to PD-1/PD-L1 blockade: a TCGA pan-cancer analysis.

Researchers

Presenter

  • Elia Segui

Principal Investigators

  • Barbara Adamo

  • Estela Pineda

  • Mercedes Marin-Aguilera

  • Oscar Reig

  • Javier Garcia Corbacho

  • Montserrat Munoz

  • Manel Juan

  • Victoria Sanchez

  • Margarita Viladot

  • Carme Font

  • Daniel Benitez

  • Cristina Nadal

  • Nuria Vinolas

  • Nuria de la Iglesia

  • Begona Mellado

  • Juan Maurel

  • Noemi Reguart

  • Aleix Prat

Medical Centers

  • Hospital Clinic de Barcelona. Universitat de Barcelona, Barcelona, Spain

  • Translational Genomics and Targeted Therapeutics in Solid Tumors Lab (IDIBAPS), Medical Oncology. Hospital Clinic Barcelona, Barcelona, Spain

  • Medical Oncology, Hospital Clinic de Barcelona, Barcelona, Spain

  • Medical Oncology, Hospital Clinic de Barcelona, Barcelona, Spain

  • Centre Diagnostic Biomedic (CDM), Barcelona, Spain

  • Hospital Clinic Barcelona, Barcelona, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Cluster of Differentiation 4

  • Programmed cell death protein 1

  • Programmed death-ligand 1

  • Cluster of differentiation 8A

  • Cytotoxic T-lymphocyte-associated protein 4

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved